The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Pfizer
PD-L1, VISTA, and CD47 expression and prognosis impact in malignant pleural mesothelioma.
 
Mercedes Herrera
Honoraria - AstraZeneca Spain
 
Álvaro C. Ucero
No Relationships to Disclose
 
Ana Belen Enguita
No Relationships to Disclose
 
Nuria Carrizo
No Relationships to Disclose
 
Ramon Yarza
No Relationships to Disclose
 
Igor Gómez-Randulfe
No Relationships to Disclose
 
Helena Bote-de-Cabo
Consulting or Advisory Role - Roche
Speakers' Bureau - AstraZeneca Spain
 
Javier Baena
Honoraria - AstraZeneca Spain; Bristol-Myers Squibb/Pfizer
Consulting or Advisory Role - AstraZeneca Spain
 
Esther García-Lorenzo
No Relationships to Disclose
 
Jon Zugazagoitia
Honoraria - AstraZeneca Spain; Bristol-Myers Squibb/Celgene; Guardant Health; NanoString Technologies; Pfizer; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene; Guardant Health; Novartis; Novartis; Pfizer
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Celgene; Guardant Health; MSD Oncology; NanoString Technologies; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Roche/Genentech
 
Luis G. Paz-Ares
Leadership - ALTUM Sequencing; Genomica
Honoraria - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Hutchmed (I); Ipsen; Lilly; Merck Serono; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sanofi; Servier; Takeda
Speakers' Bureau - AstraZeneca; BMS; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); BMS (Inst); Kura Oncology (Inst); MSD (Inst); Pfizer (Inst); PharmaMar (Inst)
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)